---
title: "Diffuse Glioma Testing Resources"
author: "W. McDonald, MD"
date: "10/31/2018"
output: html_document
---

```{r setup, include=FALSE}
knitr::opts_chunk$set(echo = TRUE)
```

## Purpose:

To provide a short list of resources for health care providers who take care of diffuse glioma patients.

## Important websites:
Sites for exploring The Cancer Genome Atlas (TCGA) data:

[cbioportal](http://www.cbioportal.org)

[firebrowse](http://firebrowse.org)

[Heidelberg methylation profiling:](https://www.molecularneuropathology.org/mnp)


## Links to important papers in DropBox:
What we know about glioblastoma:

[TCGA Nature 2008:1061](https://www.dropbox.com/s/or0sndekgttrs84/_Parsons-2008-An%20integrated%20genomi.pdf?dl=0)

### The rise of IDH1/2:
[Brat NEJM 2015:2481](https://www.dropbox.com/s/wk0p2mhb9yol7ox/_Brat_NEJM2015.pdf?dl=0) 

[Brat 2018 Acta NP](https://www.dropbox.com/s/u9pewa9gnxaheug/_Brat2018_Article_CIMPACT-NOWUpdate3Recommended.pdf?dl=0)  

[IDH mutant diffuse and anaplastic astrocytomas: pretty much the same thing](https://www.dropbox.com/s/ijmlhvj8om4cqg0/_ReussActaNP2015.pdf?dl=0)

### Why methylation of MGMT is important: 
[Hegi NEMJ 2005](https://www.dropbox.com/s/paqv9ey72y3u0ih/_HegiMGMT_GBM_NEJM2005.pdf?dl=0)

[Wick Nat Rev Neurol 2014:372](https://www.dropbox.com/s/gmhh05iuxrwafnu/_Wick2014NatRevNeurol.pdf?dl=0) 
   
### IDH-WT grade II or III infiltrating astrocytoma: GBM in sheep's clothing

[Adult IDH wild type grade II and grade III gliomas should be further stratified](https://www.dropbox.com/s/6slfkwv1d5wv40q/_AibaidulaNeuroOncol2017.pdf?dl=0)

[Adult IDH wild type grade II and III gliomas below to GBM molecular class](https://www.dropbox.com/s/wlp06zz1l7tkbw5/_ReussActaNP2015.407.pdf?dl=0)

[cIMPACT-NOW 3: Brat Acta Neuropathol 2018](https://www.dropbox.com/s/u9pewa9gnxaheug/_Brat2018_Article_CIMPACT-NOWUpdate3Recommended.pdf?dl=0) 

[Prognostic relevance of genetic alterations to diffuse lower grade gliomas](https://www.dropbox.com/s/t7pjpnrrkflyd0m/_AokiNeuroOncol2018.pdf?dl=0)

### So you want to rule out worse disease: 
[EGFR, +7 and -10](https://www.dropbox.com/s/6bol1opw2kae2st/_StichelActaNP2018.pdf?dl=0)

[Collins Acta NP 2014](https://www.dropbox.com/s/rm5aycdeq0zj752/_Collins-2014.pdf?dl=0) 
   
### Rule outs/mimics of diffuse gliomas 
Midline tumors: the Histone 3 story

### In infants and children, see especially:    
   Qaddoumi Acta Neuropathol 2016:25
   Sturm
   
### Methylation profiling based classification: what's the fuss


